Brickell Biotech Inc (NASDAQ:BBI)
| 1.18 Delayed Data As of 3:48pm ET |  -0.02 / -1.67%Today’s Change | 1.00 Today|||52-Week Range 8.89 | -21.33% Year-to-Date |
Latest BBI News | Press Releases
No recent news for Brickell Biotech Inc.
Today’s Trading
| Previous close | 1.20 |
| Today’s open | 1.24 |
| Day’s range | 1.14 - 1.24 |
| Volume | 949 |
| Average volume (3 months) | 579,950 |
| Market cap | $13.3M |
Data as of 3:48pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +92.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 0.57 |
| Price/Book | 1.55 |
Competitors
| ---- | ||
| DFFNDiffusion Pharmaceut... | -0.03 | -10.09% |
| NTECIntec Pharma Ltd | -0.03 | -13.53% |
| TTPHTetraphase Pharmaceu... | -0.36 | -21.95% |
Data as of 3:56pm ET, 03/31/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$23.9M |
| Net profit margin | -301.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
